|
|
|
LifeScienceHistory.com - Check us out on Instagram
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Akebia Therapeutics, Inc.
| | | Phone: | (617) 466-3500 | Fax: | (617) 466-3501 | Year Established: | 1998 | Ticker: | AKBA | Exchange: | NASDAQ | Main Contact: | John Butler, President & CEO | | Other Contacts: | Jason A. Amello, CFO
| |
| Company Description | Akebia Therapeutics, formed through the merger of Keryx Biopharmaceuticals and Akebia Therapeutics, is a biopharmaceutical company focused on the development of novel proprietary therapeutics based on hypoxia inducible factor, or HIF, biology and the commercialization of these products for patients with kidney disease. | |
|
|
|
|
|